FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology, and is intended for prediction of developing or progressing proliferative syndrome in endogenous uveitis in children. TGFβ1 content is examined in anterior chamber moisture of eye. If its level higher than 1,000 pg/ml, developement or progression of proliferative complications is predicted.
EFFECT: invention increases accuracy and effectiveness of prediction of developement or progression of proliferative complications of uveitis in children with prescribing adequate pathogenetic oriented preventive treatment.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLY PREDICTION OF RISK OF DEVELOPING PERIPHERAL VITREOCHORIORETINAL DYSTROPHIES ON PAIRED EYE AFTER REGMATOGENOUS RETINAL DETACHMENT SURGERIES | 2014 |
|
RU2540505C1 |
METHOD FOR PREDICTION OF ORGAN-SPECIFIC SELF-IMMUNISATION IN INFLAMMATORY EYE DISORDERS | 2014 |
|
RU2564929C1 |
METHOD OF ASSESSING INFLAMMATORY PROCESS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2023 |
|
RU2805940C1 |
WAY OF FORECASTING OF ADVANCE OF PROLIFERATIVE COMPLICATIONS AT PERIPHERIC UVEITES AT CHILDREN | 2008 |
|
RU2362172C1 |
METHOD FOR PREDICTING HIGH RISK OF AUTOIMMUNE INFLAMMATION IN POST-TRAUMATIC UVEITIS IN LONG TERM | 2021 |
|
RU2754292C1 |
METHOD FOR PREDICTING POSTERIOR AND GENERALIZED UVEITIS | 2003 |
|
RU2252704C1 |
METHOD FOR PREDICTION OF SENILE MACULAR DEGENERATION TRANSITION FROM PREDISCIFORM TO DISCIFORM STAGE IN PATIENTS WITH HYPERTENSION | 2007 |
|
RU2348043C1 |
METHOD FOR DETERMINING INDICATIONS FOR ANTIANGIOGENIC THERAPY IN CASE OF SUSPICION OF WET FORM OF AGE-RELATED MACULAR DEGENERATION | 2021 |
|
RU2758662C1 |
METHOD OF PREVENTING THE DEVELOPMENT OF PERIPHERAL RETINAL TEARS AND RETINAL DETACHMENT AFTER PHACOEMULSIFICATION WITH INTRAOCULAR LENS IMPLANTATION | 2023 |
|
RU2801484C1 |
METHOD OF INFLAMMATORY COMPLICATIONS FORECASTING WITHIN REPEATED EYE SURGICAL INTERVENTIONS | 2006 |
|
RU2330614C1 |
Authors
Dates
2016-05-20—Published
2015-07-03—Filed